Fundraising Fox

Phlow

Richmond, US · Founded 2020 · Delaware corporation

Biotech

Founders & leadership

Phlow was founded in 2020 by Rosemary Gibson, Bernard F. Gupton, and Eric Edwards.

RG
Rosemary GibsonCo-founder
BF
Bernard F. GuptonCo-founder
EE
Eric EdwardsCo-founder
EA
Elizabeth Anne WhalleyExecutive
RD
Robert DemeriaExecutive
DR
David RyanExecutive
DH
Daniel HackmanExecutive
DL
DAVID LEVINNamed on SEC filing
MV
MARTIN VAN TRIESTENamed on SEC filing
AS
ANDREW STILESNamed on SEC filing
JR
JAMES ROBERT MOONEYNamed on SEC filing
GG
GLENN GERECKENamed on SEC filing

Reported raises · per SEC filings

Form D private placements

$74.7M disclosed across 4 of 5 rounds · 2020–2025

▶$30.5MraisedFeb 2025 · 9 investors · Pharmaceuticals
Rule 506(b)
Officers, directors & promoters on the filing
  • David RyanExecutive Officer
  • Melinda HancockDirector
  • Robert DemeriaExecutive Officer
  • Marshall SummarDirector
  • Bernard GuptonDirector
  • Rosemary GibsonDirector
  • Elizabeth WhalleyExecutive Officer
  • Guido VillaxDirector
  • Thomas O'MalleyDirector
  • Daniel HackmanExecutive Officer
  • Anna Maria NekoranecDirector
  • Kerry IngallsDirector
  • Eric EdwardsExecutive Officer, Director
Offering amount
$40M
Amount sold
$30.5M
First sale
Jan 2025
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$5MraisedJul 2024 · 1 investors · Pharmaceuticals
Rule 506(b)
Officers, directors & promoters on the filing
  • Guido VillaxDirector
  • Elizabeth Anne WhalleyExecutive Officer
  • Thomas D. O'MalleyDirector
  • Rosemary GibsonDirector
  • Robert DemeriaExecutive Officer
  • Melinda HancockDirector
  • David RyanExecutive Officer
  • Bernard F. GuptonDirector
  • Daniel HackmanExecutive Officer
  • Eric EdwardsExecutive Officer, Director
  • Marshall SummarDirector
  • Kerry IngallsDirector
Offering amount
$25M
Amount sold
$5M
First sale
Jun 2024
Incorporated
Corporation, Delaware, 2020
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$24.2MraisedSep 2022 · 11 investors · Pharmaceuticals
Rule 506(b)
Officers, directors & promoters on the filing
  • DAVID LEVINExecutive Officer
  • RON BARDENExecutive Officer
  • ROBERT DEMERIAExecutive Officer
  • GLENN GERECKEExecutive Officer
  • MARSHALL SUMMARDirector
  • ROSEMARY GIBSONDirector
  • DANIEL HACKMANExecutive Officer
  • THOMAS D. O'MALLEYDirector
  • ELIZABETH WHALLEY BUONOExecutive Officer
  • BERNARD F. GUPTONDirector
  • MARTIN VAN TRIESTEDirector
  • ERIC EDWARDSExecutive Officer, Director
Offering amount
$50M
Amount sold
$24.2M
Proceeds to insiders
$2M
First sale
Aug 2022
Incorporated
Corporation, Delaware, 2020
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$15MraisedNov 2020 · 4 investors · Pharmaceuticals
Rule 506(b)
Officers, directors & promoters on the filing
  • DANIEL HACKMANExecutive Officer
  • ANDREW STILESExecutive Officer
  • ROBERT DEMERIAExecutive Officer
  • DAVID LEVINExecutive Officer
  • BERNARD F. GUPTONDirector
  • MARTIN VAN TRIESTEDirector
  • ROSEMARY GIBSONDirector
  • MARSHALL SUMMARDirector
  • THOMAS D. O'MALLEYDirector
  • ERIC EDWARDSExecutive Officer, Director
  • GLENN GERECKEExecutive Officer
  • JAMES ROBERT MOONEYExecutive Officer
Offering amount
$20M
Amount sold
$15M
First sale
Nov 2020
Incorporated
Corporation, Delaware, 2020
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$8.1MofferedNov 2020 · 6 investors · Pharmaceuticals
Rule 506(b)
Officers, directors & promoters on the filing
  • DAVID LEVINExecutive Officer
  • THOMAS D. O'MALLEYDirector
  • MARSHALL SUMMARDirector
  • ROSEMARY GIBSONDirector
  • MARTIN VAN TRIESTEDirector
  • BERNARD F. GUPTONDirector
  • ROBERT DEMERIAExecutive Officer
  • ANDREW STILESExecutive Officer
  • DANIEL HACKMANExecutive Officer
  • JAMES ROBERT MOONEYExecutive Officer
  • GLENN GERECKEExecutive Officer
  • ERIC EDWARDSExecutive Officer, Director
Offering amount
$8.1M
First sale
Nov 2020
Incorporated
Corporation, Delaware, 2020
Federal exemptions
06b
Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.

In the news

Phlow raises $37M in Series C roundvirginiabusiness.com · Jul 2025Richmond pharma company Phlow secures $37M capital raise - Richmond BizSenserichmondbizsense.com · Jul 2025Richmond Inno - Phlow touts expansion, investment in Richmond and Petersburgbizjournals.com · Apr 2025Contract manufacturer Phlow raises $36M to build out servicesendpoints.news · Apr 2023Richmond pharmaceutical giant Phlow raises $36 millionrichmond.com · Apr 2023Phlow Announces over $35M in Series B Funding to Improve the U.S. Medicine Supply Chainglobenewswire.com · Apr 2023

Frequently asked questions

Who founded Phlow?
Phlow was founded by Rosemary Gibson, Bernard F. Gupton, Eric Edwards in 2020.
How much funding has Phlow raised?
Phlow has disclosed $74.7M raised across 4 of its 5 known rounds.
Where is Phlow headquartered?
Phlow is headquartered in Richmond, US.